[
  {
    "ts": "2025-10-09T18:17:32+00:00",
    "headline": "Should Moderna's (MRNA) Improved Revenue Trends Prompt New Action From Investors?",
    "summary": "Moderna recently reported marked improvements in annual revenue growth and profit margins, capturing renewed investor attention over the past week. Analyst expectations for positive upcoming earnings, supported by favorable financial indicators and stronger operating results, have contributed to increased optimism around the company's near-term outlook. We'll explore how Moderna's improving annual revenue growth and earnings expectations could influence its broader investment...",
    "url": "https://finance.yahoo.com/news/modernas-mrna-improved-revenue-trends-181732725.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "f41f0794-be93-35dc-aa10-9b0e2172d89c",
      "content": {
        "id": "f41f0794-be93-35dc-aa10-9b0e2172d89c",
        "contentType": "STORY",
        "title": "Should Moderna's (MRNA) Improved Revenue Trends Prompt New Action From Investors?",
        "description": "",
        "summary": "Moderna recently reported marked improvements in annual revenue growth and profit margins, capturing renewed investor attention over the past week. Analyst expectations for positive upcoming earnings, supported by favorable financial indicators and stronger operating results, have contributed to increased optimism around the company's near-term outlook. We'll explore how Moderna's improving annual revenue growth and earnings expectations could influence its broader investment...",
        "pubDate": "2025-10-09T18:17:32Z",
        "displayTime": "2025-10-09T18:17:32Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lV6Oo0M_C3X63uXoBkpnwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KdbFtaQiMRVA6Enl712wNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/modernas-mrna-improved-revenue-trends-181732725.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/modernas-mrna-improved-revenue-trends-181732725.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]